Agvantar (levocarnitine) oral solution 20% 30 ml. №1+ syringe

Description

Composition

active substance: levocarnitine;

1 ml of solution contains:

• levocarnitine 200 mg;

auxiliary substances: methylparaben (E 218), propylparaben (E 216), sucrose, sorbitol (E 420), flavoring “banana”, purified water.

Pharmacodynamics.

Levocarnitine (L-carnitine) is a vitamin-like substance that is naturally synthesized in the liver, kidneys and brain tissue from the amino acids lysine and methionine with the participation of iron and ascorbic acid. It is found in blood plasma in free form and in the form of acylcarnitine esters. Levocarnitine is the main cofactor in the exchange of fatty acids in the heart, liver and skeletal muscles, plays the role of the main carrier of long-chain fatty acids in the mitochondria, where their beta-oxidation to acetyl-CoA occurs, followed by the formation of ATP. Promotes the removal of metabolites and toxic substances from the cytoplasm, improves metabolic processes, increases work capacity, accelerates growth, causes an increase in muscle mass and a decrease in the amount of fat in adipocytes, contributes to the normalization of the basic metabolism in hyperthyroidism. Reduces symptoms of physical and mental overstrain, exerts a neuro-, hepato- and cardioprotective effect, helps reduce myocardial ischemia and limit the infarct zone, lowers cholesterol in the blood, stimulates cellular immunity, increases concentration of attention. Levocarnitine eliminates functional disorders of the nervous system in patients with chronic alcoholism with withdrawal syndrome. During intense physical exertion and sports, carnitine increases endurance, increases the pain threshold of muscles, optimizes the work of skeletal muscles and heart muscle.

Indication

• Primary (congenital) carnitine deficiency.
• Secondary carnitine deficiency.

Contraindications to Agvantar

• Increased sensitivity to the components of the drug.

Agvantar should be taken orally 30 minutes before eating. To dose the drug, use a dosing syringe or a measuring cup.

The maximum daily dose is 3 g. The average course of treatment for adults and children is 1-3 months. If necessary, the course of treatment can be repeated. In the case of primary and secondary carnitine deficiency, the drug should be taken continuously or until the cause of the latter is eliminated.